- ONM-501 is a dual-activating polyvalent STING agonist for immuno-oncology applications formulated with OMNI™, the company’s core immune activating polymer technology - “We are thrilled by the ...
GRAPEVINE, Texas--(BUSINESS WIRE)--ONM Living, a fully integrated build-for-rent company that leverages 73 years of development and construction expertise, announces the sale of Cottages at Bell ...
WESTMINSTER, CA / ACCESSWIRE / July 1, 2020 / BioLargo, Inc. (OTCQB:BLGO), developer of sustainable technologies and a full-service environmental engineering company, announced that its wholly-owned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results